Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Robert A. Burger, MD

Robert A. Burger, MD Physician

Director of Clinical Research and Fellowship Program in Gynecologic Oncology Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Burger is employed by Penn Medicine.

About Dr. Robert A. Burger

Recognized by America's Top Doctors, 2014 - 2018

Recognized by Best Doctors in America - 2013 - 2018

Recognized by Philadelphia magazine's annual Top Docs issues 2014 - 2018

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Gynecologic Oncology

Programs & Centers:

Board Certification:

  • ObGyn/GynecologicOncology (AMA)
  • Obstetrics and Gynecology, 1997

Clinical Expertise:

  • Cervical Cancer
  • Cervical Dysplasia
  • Cervical Lesions
  • Cervix Biopsy
  • Chemotherapy for Gynecologic Cancers
  • Colposcopy
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Cancer
  • Gynecologic Cancer Surgery
  • Gynecologic Surgery
  • Gynecology Clinical Trials
  • Hysterectomy (Uterus Surgery)
  • Hysteroscopy
  • Laparoscopic Hysterectomy
  • Laparoscopic Supracervical Hysterectomy
  • Laparoscopic Surgery
  • Laparoscopy
  • Loop Electrosurgical Excision Procedure (LEEP)
  • Minimally Invasive Hysterectomy
  • Ovarian Cancer
  • Robotic Surgery
  • Trophoblastic Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: New York University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: UC at Irvine Medical Center

Memberships

American Association for Cancer Research (AACR), National American College of Obstetricians and Gynecologists, National American College of Surgeons (FACS), fellow, National GOG Foundation, National Gynecologic Oncology Group, National National Cancer Institute (NCI), Investigator, National NRG Oncology, International NRG Oncology, National Ovarian Cancer National Alliance Scientific and Medical Advisory Board, National Society of Gynecologic Oncology (SGO), National Tina's Wish Foundation, National

Hospital Affiliation

Dr. Burger is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Burger RA; Sill M; Zamarin D; Powell D; Frak I; Zivanovic O; Gunderson C; Ko E; Mathews C; Sharma S; Hagemann A; Khleif S; Aghajanian C: NRG Oncology Phase II Randomized Trial of Nivolumab with or without Ipilimumab in Patients with Persistent or Recurrent Ovarian Cancer. Late breaking abstract oral presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Does chemotherapy improve survival of patients with stage II high-grade endometrioid carcinoma of the uterus.Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Radical hysterectomy for the management of FIGO stage II type II uterine cancer; use and outcomes. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Mastroyannis SA; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Trends in the surgical management of malignant ovarian germ-cell tumors. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Type of treatment facility impacts survival of patients with ovarian clear cell carcinoma. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Kanninen T; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Residual disease is associated with a worse prognosis in patients with advanced stage sex cord-stromal tumors. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Does surgical approach influence the rate of positive peritoneal cytology and lymph-vascular invasion for patients with stage I uterine cancer. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Is adjuvant chemotherapy associated with a survival benefit for patients with stage I mucinous ovarian carcinoma?” Oral presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Minimally invasive staging for stage I type II uterine cancer: use and outcomes. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Nasioudis D; Mastroyannis SA; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA.: Presence of lymph-vascular invasion is associated with a worse prognosis for patients with advanced stage malignant ovarian germ cell tumors. Poster presentation at the Biennial Meeting of the International Society of Gynecologic Cancer, Kyoto, Japan. (Abstract) : 2018.

Academic Contact Info

University of Pennsylvania
3400 Civic Center Blvd.
Smilow CTR 8-104

Philadelphia, PA 19104-5156
Phone: (215) 746-4043
Patient appointments: 800-789-7366 (PENN)